Basware and Novartis extend cooperation to global level BASWARE CORP. STOCK EXCHANGE RELEASE APRIL 16, 2008 Basware has agreed to extend the delivery of Basware Enterprise Purchase to Pay solution to Novartis' offices globally. The product implementation program is scheduled for two years. The value of the agreement in 2008 is estimated to be at minimum EUR 1 million. Novartis Pharma has been using Basware Enterprise Purchase to Pay product portfolio since 2006 in various European countries. Now the cooperation has been extended to global level and Basware offers its solutions to Novartis Pharma business units across the world."We are always pleased to deliver geographical extensions to our existing customers as it attests to customer satisfaction. Larger and larger companies see the benefits of implementing an end-to-end solution from Basware," says Ilkka Sihvo, CEO, Basware Corporation. Basware Enterprise Purchase to Pay suite includes solutions for automated invoice processing and procurement. Basware Key Performance Indicator (KPI) Reporting Tool measures cost, quality, productivity, strategic alignment and employee and supplier specific issues of the purchase to pay process. For more information, please contact CEO Ilkka Sihvo, Basware Corp. Tel. +358 40 501 8251 BASWARE CORP. Ilkka Sihvo Distribution OMX Nordic Exchange Helsinki Key media www.basware.com